BeiGene proposes new name, reaffirming oncology mission
By Catherine Eckford (European Pharmaceutical Review)
BioNTech oncology acquisition to advance bispecific antibodies
By Catherine Eckford (European Pharmaceutical Review)
New $3.5b AstraZeneca investment to accelerate US R&D and manufacturing
By Catherine Eckford (European Pharmaceutical Review)
Innovative static culturing method developed
By Catherine Eckford (European Pharmaceutical Review)